Metformin history
Pro Research Analysisby 
Searched over 200M research papers for "metformin history"
Origins of Metformin: Galega officinalis and Early Discoveries
Metformin’s history begins with Galega officinalis, also known as goat’s rue, a plant used in traditional European medicine for its blood sugar-lowering properties. The active compound, guanidine, was identified in 1918 as effective in reducing blood glucose. This discovery led to the synthesis of guanidine derivatives, including metformin, in the early 20th century. However, initial use of these compounds was limited due to toxicity concerns and the rise of insulin therapy in the 1920s and 1930s Bailey2017Song2016Ursini2018.
Rediscovery and Clinical Introduction of Metformin
Metformin was rediscovered in the 1940s during research for antimalarial drugs. Its glucose-lowering effect was noted during clinical tests for influenza. French physician Jean Sterne was the first to report metformin’s use in diabetes treatment in 1957. Despite this, metformin received little attention at first, as other biguanides (phenformin and buformin) were more potent but later withdrawn due to safety issues, particularly lactic acidosis. Metformin’s reputation suffered by association, but its better safety profile eventually distinguished it from its counterparts Bailey2017Song2016.
Global Adoption and Regulatory Milestones
Metformin gradually gained acceptance in Europe for its ability to lower blood sugar without causing weight gain or hypoglycemia. After extensive safety reviews, it was introduced in the United States in 1995, nearly 40 years after its European debut. The UK Prospective Diabetes Study (UKPDS) in 1998 confirmed metformin’s cardiovascular benefits, solidifying its role as the first-line therapy for type 2 diabetes Bailey2017Song2021Salvatore2020+1 MORE.
Expanding Clinical Applications and Research
Since the 1980s, research and clinical use of metformin have expanded rapidly. It is now the most prescribed glucose-lowering medication worldwide, with over 150 million daily users. Beyond type 2 diabetes, metformin is used in conditions like polycystic ovary syndrome (PCOS), obesity, and even type 1 diabetes to reduce insulin requirements. Ongoing studies are exploring its potential in cancer prevention, cardiovascular disease, neurodegenerative disorders, and aging Song2021Thomas2017Salvatore2020+5 MORE.
Mechanisms and Safety Profile
Metformin’s primary action is to reduce hepatic glucose production, improving insulin sensitivity without increasing insulin secretion or causing weight gain. Its safety profile is superior to other biguanides, with a very low risk of lactic acidosis. Metformin is also being studied for its effects on the gut, immune modulation, and possible anti-aging properties Bailey2017Song2016Triggle2022+4 MORE.
Conclusion
Metformin’s journey from a plant extract to a globally essential medicine highlights its unique safety and efficacy in managing type 2 diabetes. Over the past 60 years, its clinical uses have broadened, and ongoing research continues to reveal new therapeutic possibilities. Metformin remains a cornerstone of diabetes care and a promising candidate for future applications in various diseases and health conditions Bailey2017Song2021Thomas2017+7 MORE.
Sources and full results
Most relevant research papers on this topic